Literature DB >> 31753191

How It Works: The Immunology Underlying Phototherapy.

Zizi Yu1, Peter Wolf2.   

Abstract

Phototherapeutic modalities induce apoptosis of keratinocytes and immune cells, impact cytokine production, downregulate the IL-23/Th17 axis, and induce regulatory T cells. As in anti-IL-17 or anti-IL-23 antibody treatment, the dual action of phototherapy on skin and the immune system is likely responsible for sustained resolution of lesions in diseases such as psoriasis. In cutaneous T cell lymphoma, phototherapy may function by causing tumor cell apoptosis and eliminating the neoplastic and inflammatory infiltrate. Further research on phototherapeutic mechanisms will help advance, optimize, and refine dermatologic treatments and may open up novel avenues for treatment strategies in dermatology and beyond.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ); Apoptosis; IL-23/T(H)17 axis; Immunosuppression; Phototherapy; Platelet-activating factor; Regulatory T cells (Tregs; UV radiation; Urocanic acid

Mesh:

Year:  2020        PMID: 31753191     DOI: 10.1016/j.det.2019.08.004

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  9 in total

Review 1.  Extracorporeal Photopheresis: A Case of Immunotherapy Ahead of Its Time.

Authors:  Pablo Augusto Vieyra-Garcia; Peter Wolf
Journal:  Transfus Med Hemother       Date:  2020-05-27       Impact factor: 3.747

Review 2.  Potential of Skin Microbiome, Pro- and/or Pre-Biotics to Affect Local Cutaneous Responses to UV Exposure.

Authors:  VijayKumar Patra; Irène Gallais Sérézal; Peter Wolf
Journal:  Nutrients       Date:  2020-06-17       Impact factor: 5.717

3.  Accumulation of Cytotoxic Skin Resident Memory T Cells and Increased Expression of IL-15 in Lesional Skin of Polymorphic Light Eruption.

Authors:  VijayKumar Patra; Johanna Strobl; Denise Atzmüller; Bärbel Reininger; Lisa Kleissl; Alexandra Gruber-Wackernagel; Jean-Francois Nicolas; Georg Stary; Marc Vocanson; Peter Wolf
Journal:  Front Med (Lausanne)       Date:  2022-06-10

4.  Pilot phase results of a prospective, randomized controlled trial of narrowband ultraviolet B phototherapy in hospitalized COVID-19 patients.

Authors:  Frank H Lau; Catherine E Powell; Giacomo Adonecchi; Denise M Danos; Andrew R DiNardo; Robert J Chugden; Peter Wolf; Carmen F Castilla
Journal:  Exp Dermatol       Date:  2022-06-13       Impact factor: 4.511

5.  Pretreatment with an Aerosol Foam Containing Calcipotriene and Betamethasone Strongly Improves the Efficacy of Narrow-Band UVB Phototherapy.

Authors:  Gaetano Licata; Mariachiara Arisi; Marina Venturini; Mariateresa Rossi; Cesare Tomasi; Irene Calzavara-Pinton; Piergiacomo Calzavara-Pinton
Journal:  Dermatol Ther (Heidelb)       Date:  2022-08-26

6.  Climatotherapy at the Dead Sea for psoriasis is a highly effective anti-inflammatory treatment in the short term: An immunohistochemical study.

Authors:  Thomas Emmanuel; Annita Petersen; Hannah Inez Houborg; Anders Benjamin Rønsholdt; Dorte Lybaek; Torben Steiniche; Anne Bregnhøj; Lars Iversen; Claus Johansen
Journal:  Exp Dermatol       Date:  2022-02-27       Impact factor: 4.511

7.  The 2022 British guidelines for narrowband ultraviolet B phototherapy: an absolute necessity for anyone administering or prescribing phototherapy.

Authors:  Peter Wolf
Journal:  Br J Dermatol       Date:  2022-07-11       Impact factor: 11.113

8.  Induction of IL-1β and antimicrobial peptides as a potential mechanism for topical dithranol.

Authors:  Theresa Benezeder; Ahmed Gehad; VijayKumar Patra; Rachael Clark; Peter Wolf
Journal:  Exp Dermatol       Date:  2021-02-25       Impact factor: 3.960

9.  Long-Term Course of Polymorphic Light Eruption: A Registry Analysis.

Authors:  Alexandra Gruber-Wackernagel; Tanja Schug; Thomas Graier; Franz J Legat; Hanna Rinner; Angelika Hofer; Franz Quehenberger; Peter Wolf
Journal:  Front Med (Lausanne)       Date:  2021-07-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.